Source: Citybizlist

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

CEO

Jason Gardner

CEO Approval Rating

90/100

Ampersand is a Massachusetts-based biotechnology platform that researches and develops programmable drugs to precisely treat the affected body part.

Ampersand received $65M in Series B Funding